This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets. New marketing authorisations Table 1 shows the new marketing authorisations for January 2022. TABLE 1: New marketing authorisations in January 2022 New Marketing Authorisations Product name and target species Active substance Authorisation Holder, territory, and distribution category Therapeutic group F

The Standards Committee of the Royal College of Veterinary Surgeons has this week decided that the temporary dispensation allowing remote prescribing of prescription-only veterinary medicines will end on Monday 14 March 2022. The dispensation was originally introduced during the spring 2020 lockdown to safeguard animal health and welfare, the health and safety of the veterinary team, and public health, by allowing prescriptions to be made by veterinary surgeons without their having first physica

This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets. Changes to authorisations most relevant to vets The changes to authorisations most relevant to vets can be found below. Each product listed, along with the authorisation holder, distribution category and details of which Summary of Product Characteristics sections have been revised/changed. All entries ca